TP53 and breast cancer: Given the dependence of the senescence program on the tumor suppressor pathways Arf-p53 and pRB-p16INK4A [1,15], we investigated the degree to which SA-β-gal-positive tumor cells within the primary breast cancer and their related metastases samples also express p53 and p16INK4A.